MX364626B - Péptidos miméticos. - Google Patents
Péptidos miméticos.Info
- Publication number
- MX364626B MX364626B MX2015005761A MX2015005761A MX364626B MX 364626 B MX364626 B MX 364626B MX 2015005761 A MX2015005761 A MX 2015005761A MX 2015005761 A MX2015005761 A MX 2015005761A MX 364626 B MX364626 B MX 364626B
- Authority
- MX
- Mexico
- Prior art keywords
- mimetic peptides
- methods
- mimetic
- peptides
- apolipoprotein
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000005666 Apolipoprotein A-I Human genes 0.000 abstract 1
- 108010059886 Apolipoprotein A-I Proteins 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 238000003018 immunoassay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12191474 | 2012-11-06 | ||
| PCT/IB2013/059948 WO2014072916A1 (en) | 2012-11-06 | 2013-11-06 | Mimetic peptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015005761A MX2015005761A (es) | 2015-08-12 |
| MX364626B true MX364626B (es) | 2019-05-03 |
Family
ID=47115623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015005761A MX364626B (es) | 2012-11-06 | 2013-11-06 | Péptidos miméticos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10087234B2 (https=) |
| EP (1) | EP2917234B1 (https=) |
| JP (1) | JP6499967B2 (https=) |
| KR (1) | KR102215175B1 (https=) |
| CN (1) | CN104768970B (https=) |
| BR (1) | BR112015010276A2 (https=) |
| CA (1) | CA2888657C (https=) |
| ES (1) | ES2859559T3 (https=) |
| MX (1) | MX364626B (https=) |
| RU (1) | RU2662973C2 (https=) |
| WO (1) | WO2014072916A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019008529A (es) | 2017-01-19 | 2020-02-07 | Us Health | Peptidos mimeticos de apolipoproteina c-ii (apoc-ii). |
| MX2020010716A (es) | 2018-04-10 | 2021-03-09 | Sanofi Aventis Deutschland | Metodo para escindir de la fase solida peptidos unidos a una fase solida. |
| EP3774838B9 (en) * | 2018-04-10 | 2025-12-10 | Sanofi-Aventis Deutschland GmbH | Lixisenatide synthesis with capping |
| CN108948158B (zh) * | 2018-07-21 | 2021-06-15 | 河南大学 | 四连接素模拟肽tnp及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6664230B1 (en) | 2000-08-24 | 2003-12-16 | The Regents Of The University Of California | Orally administered peptides to ameliorate atherosclerosis |
| SE0103754L (sv) | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
| WO2005058938A2 (en) * | 2003-12-15 | 2005-06-30 | The Regents Of The University Of California | Helical synthetic peptides that stimulate cellular cholesterol efflux |
| US7972770B2 (en) * | 2005-08-16 | 2011-07-05 | Memorial Sloan-Kettering Cancer Center | Methods of detection of cancer using peptide profiles |
| AU2008266753A1 (en) | 2007-06-20 | 2008-12-24 | Istituto Di Recerche Di Biologia Molecolare P. Angeletti S.P.A. | ApoA-1 peptide mimetics |
| WO2012040459A2 (en) * | 2010-09-22 | 2012-03-29 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
| CA2834657A1 (en) * | 2011-04-29 | 2012-11-01 | Kinemed, Inc. | Chemical modification of apolipoprotein mimetic peptides for the production of therapeutic agents |
-
2013
- 2013-11-06 BR BR112015010276A patent/BR112015010276A2/pt not_active IP Right Cessation
- 2013-11-06 JP JP2015540267A patent/JP6499967B2/ja not_active Expired - Fee Related
- 2013-11-06 EP EP13792995.6A patent/EP2917234B1/en active Active
- 2013-11-06 RU RU2015121688A patent/RU2662973C2/ru active
- 2013-11-06 KR KR1020157013810A patent/KR102215175B1/ko not_active Expired - Fee Related
- 2013-11-06 WO PCT/IB2013/059948 patent/WO2014072916A1/en not_active Ceased
- 2013-11-06 CA CA2888657A patent/CA2888657C/en active Active
- 2013-11-06 CN CN201380057907.5A patent/CN104768970B/zh not_active Expired - Fee Related
- 2013-11-06 ES ES13792995T patent/ES2859559T3/es active Active
- 2013-11-06 MX MX2015005761A patent/MX364626B/es active IP Right Grant
- 2013-11-06 US US14/440,790 patent/US10087234B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2917234B1 (en) | 2020-12-02 |
| ES2859559T3 (es) | 2021-10-04 |
| CA2888657A1 (en) | 2014-05-15 |
| US20150291682A1 (en) | 2015-10-15 |
| JP6499967B2 (ja) | 2019-04-10 |
| MX2015005761A (es) | 2015-08-12 |
| JP2016505514A (ja) | 2016-02-25 |
| WO2014072916A1 (en) | 2014-05-15 |
| KR20150082350A (ko) | 2015-07-15 |
| CN104768970A (zh) | 2015-07-08 |
| RU2015121688A (ru) | 2016-12-27 |
| US10087234B2 (en) | 2018-10-02 |
| EP2917234A1 (en) | 2015-09-16 |
| RU2662973C2 (ru) | 2018-07-31 |
| CN104768970B (zh) | 2019-11-15 |
| CA2888657C (en) | 2022-05-03 |
| KR102215175B1 (ko) | 2021-02-15 |
| BR112015010276A2 (pt) | 2019-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ718280A (en) | Antibodies against claudin 18.2 useful in cancer diagnosis | |
| WO2014124334A3 (en) | Transthyretin antibodies and uses thereof | |
| CY1122978T1 (el) | Αντισωματα εναντι-vla-4 | |
| WO2014160499A3 (en) | Methods and compositions for detecting pancreatic cancer | |
| WO2014031859A3 (en) | Compositions and methods relating to blood-based biomarkers of breast cancer | |
| WO2014150877A3 (en) | Anti-tau antibodies and methods of use | |
| IN2014DN05885A (https=) | ||
| CL2014001994A1 (es) | Polipeptido mimético de apelina sintéticos para el tratamiento e insuficiencia cardiaca; composicion farmacéutica que comprende dicho polipeptido. | |
| WO2016014974A3 (en) | Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same | |
| EA201391175A1 (ru) | Гетеродимерные иммуноглобулины | |
| HK1199290A1 (en) | Methods and compositions for the treatment and diagnosis of breast cancer | |
| MY195289A (en) | Anti IL-36R Antibodies | |
| MX357202B (es) | Composicion de particula tipo virus. | |
| WO2014152157A3 (en) | Methods and compositions for the generation and use of conformation-specific antibodies | |
| MX2014012978A (es) | Regiones de anticuerpo modificado y sus usos. | |
| TN2012000366A1 (en) | Anticoagulant antidotes | |
| WO2012173846A3 (en) | Peptidomimetic macrocycles | |
| UA106900C2 (uk) | Агоністичний dr5-зв'язувальний поліпептид | |
| HK1209159A1 (en) | Methods of decellularizing bone | |
| SG10201907901XA (en) | Antibodies, uses & methods | |
| TN2013000373A1 (en) | Pharmaceutical formulation comprising inositol | |
| WO2016057683A3 (en) | Novel anti-nodal antibodies and methods of using same | |
| PH12015501099A1 (en) | Synbiotic composition and use thereof | |
| WO2015023508A3 (en) | Methods for improving asthma symptoms using benralizumab | |
| WO2012064743A3 (en) | Methods for improving heart function |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |